These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1212435)

  • 41. [Plasma platelet factor 4 levels in diabetics with various vascular complications: measurement by radiommunoassay (author's transl)].
    Tsukada T; Tsutsui K; Ito T
    Rinsho Ketsueki; 1980 Mar; 21(3):302-7. PubMed ID: 7411869
    [No Abstract]   [Full Text] [Related]  

  • 42. [Molecular structure of human fibrin stabilizing factors].
    Bohn H; Haupt H; Kranz T
    Blut; 1972 Oct; 25(4):235-48. PubMed ID: 5077426
    [No Abstract]   [Full Text] [Related]  

  • 43. [Platelet membrane and coagulation].
    Sugo T; Iwanaga S
    Nihon Rinsho; 1979; 37(8):3131-7. PubMed ID: 390185
    [No Abstract]   [Full Text] [Related]  

  • 44. Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.
    Francis CW; Marder VJ
    J Clin Invest; 1987 Nov; 80(5):1459-65. PubMed ID: 3680507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in coagulation fibrinolytic factors in cerebral thrombosis].
    Inaba H
    Nihon Ika Daigaku Zasshi; 1987 Dec; 54(6):631-41. PubMed ID: 2449449
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of the fibrin stabilizing factor in human platelets: its content in normal thrombocytes and in platelets with functional defects.
    Wenzel E; Oppolzer R
    Acta Univ Carol Med Monogr; 1972; 53():173-8. PubMed ID: 4133928
    [No Abstract]   [Full Text] [Related]  

  • 47. [Blood platelets and fibrin stabilizing factor activity].
    Isobe J; Kawano K; Yamanaka M
    Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):696-7. PubMed ID: 5535827
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets.
    McLaren KM; Pepper DS
    J Clin Pathol; 1982 Nov; 35(11):1227-31. PubMed ID: 6183294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The heparin neutralizing activity test in the diagnosis of acute myocardial infarction (MI).
    O'Brien JR; Etherington MD; Jamieson S; Lawford P; Sussex J
    Adv Exp Med Biol; 1977; 82():136-8. PubMed ID: 920346
    [No Abstract]   [Full Text] [Related]  

  • 50. [Heparin complex formation with plasma fibrin-stabilizing factor in vitro].
    Ul'ianov AM; Kudriashov BA; Liapina LA
    Biokhimiia; 1973; 38(6):1281-7. PubMed ID: 4802010
    [No Abstract]   [Full Text] [Related]  

  • 51. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor.
    Weiss HJ; Witte LD; Kaplan KL; Lages BA; Chernoff A; Nossel HL; Goodman DS; Baumgartner HR
    Blood; 1979 Dec; 54(6):1296-319. PubMed ID: 508939
    [No Abstract]   [Full Text] [Related]  

  • 52. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 53. [Coagulation factors in human born blisters (author's transl)].
    Burkhardt H; Zellner PR
    Blut; 1977 Sep; 35(3):241-6. PubMed ID: 912108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface.
    Dale GL; Friese P; Batar P; Hamilton SF; Reed GL; Jackson KW; Clemetson KJ; Alberio L
    Nature; 2002 Jan; 415(6868):175-9. PubMed ID: 11805836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Postsurgical alterations of monoidodoacetate-tolerance (factor 13 activity)].
    Matis P; Dürr W
    Arztl Forsch; 1969 Apr; 23(4):147-51. PubMed ID: 5305779
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study.
    Gerlach R; Tölle F; Raabe A; Zimmermann M; Siegemund A; Seifert V
    Stroke; 2002 Jun; 33(6):1618-23. PubMed ID: 12053001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulation factors of the newborn and his mother.
    Biland L; Duckert F
    Thromb Diath Haemorrh; 1973 Jun; 29(3):644-51. PubMed ID: 4761831
    [No Abstract]   [Full Text] [Related]  

  • 59. Platelet consumption and plasma concentration of platelet factor 4 (PF-J).
    Gjesdal K; Abrahamsen AF
    Scand J Haematol; 1976 Jul; 17(1):5-9. PubMed ID: 959773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraglomerular localization of platelet related antigens, platelet factor 4 and beta-thromboglobulin in glomerulonephritis.
    Duffus P; Parbtani A; Frampton G; Cameron JS
    Clin Nephrol; 1982 Jun; 17(6):288-97. PubMed ID: 6179675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.